市場調査レポート

iPS細胞分化の特許情勢

iPS Cells Differentiation - Patent Overview 2013

発行 France Innovation Scientifique et Transfert (FIST SA) 商品コード 269662
出版日 ページ情報 英文 70 Slides
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
iPS細胞分化の特許情勢 iPS Cells Differentiation - Patent Overview 2013
出版日: 2013年04月30日 ページ情報: 英文 70 Slides
概要

当レポートは、iPS細胞分化関連特許について取り上げ、出願動向、出願者、投資家、ポートフォリオおよび引用・延長・許諾特許の分析を提供しており、概略下記の構成でおとどけします。

総論

  • 技術の概要
  • 世界的なiPS細胞関連の特許および特許アプリケーション関連の検索戦略

特許出願の発展とロケーション

  • 特許出願の発展
  • 優先出願のマップ・発展
  • 延長のマップ

特許出願者の分析

  • 全期間中の主要出願者
  • ポートフォリオの一部は最初の10出願者が保有
  • 主要機関/産業出願者の出願分析
  • 出願者間の主な共同出願
  • 出願者とその関係先

投資家の分析

  • 主要投資家のリスト
  • 主要研究チーム

ポートフォリオの分析

  • ポートフォリオの分析
  • 特許ポートフォリオの分析

引用・延長・許諾特許の分析

  • 最も引用された特許・特許アプリケーションのリスト
  • 最も延長された特許・特許アプリケーションのリスト
  • 許諾特許群
目次

Abstract

Description/Summary

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged tissues using differentiated cells out of stem cells. However, ethical and scientific issues are related to the use of embryonic stem cells. In this context, induced pluripotent stem cells (iPS) appear as a promising approach. The patient's somatic cells are first dedifferentiated into iPS cells and then redifferentiated into the cell of interest. This revolutionary technology represents major scientific, societal and economic challenges and was recently rewarded by a Nobel Prize in Physiology and Medicine to Prof. Shinya Yamanaka and Prof. John Gurdon.

With over 1000 patent families qualified and analyzed out of a pool of 3000 patent families, we have analysed:

The "iPS cells generation" patent landscape

The analysis of this patent landscape shows a strong complexity of the environment and demonstrates the ability of institutional players to develop a consistent IP strategy like the one from Kyoto university. Some major players already present in 2011 increased sharply their filings: the Kyoto university, the Chinese Academy of Sciences, the laboratories of US government. New entrants have filed numerous patent applications in the last years: Korea university, AIST, Cellular Dynamics, Salk Institute and A*STAR (SG).

The "iPS cells differentiation" patent landscape

As for the thematic "iPS cells generation", the main players are mainly institutional (23 institutional applicants in the top 30) with the university of Kyoto and the laboratories of the US government at the first two places. However, industrial applicants from all over the world clearly positioned themselves on the thematic such as Cellular Dynamics (US), Cellectis (FR) or Viacyte (US).

The technological breakdowns presented in this study had shown specific positioning of the players through their patent applications notably regarding the type of cell obtained from the differentiation of iPS cells. Cardiovascular, neural, pancreatic cells are the most claimed by the applicants, this corresponding to the main pathologies observed nowadays. Hepatic cells are also often claimed notably for the establishment of toxicology studies.

The "iPS cells database"

Additionally, all patents dealing with iPS cells but who were concerning neither generation nor differentiation (thus all patents related to culture, selection, isolation, etc...) were grouped together in a database to get a full overview of the iPS landscape.

These patent landscapes provide you a comprehensive panorama of the intellectual property overview and help you:

  • Identify key inventors and players involved in the generation and differentiation of iPS cells
  • Understand their positioning, the collaboration networks and their dynamics
  • Analyze their IP strategy
  • Position your company's R&D and IP portfolio
  • Discover new trends and emerging topics

Table of Contents

Overview

Generalities

  • Brief outline of the technology
  • Global search strategy of patents and patent applications related to iPS cells

Evolution and location of patent filings

  • Evolution of patent filings
  • Map and evolution of priority filings
  • Map of extensions

Analysis of patent applicants

  • Main applicants on the entire period (2004-2012)
  • Part of the portfolio hold by the first 10 applicants
  • Breakdown of filings of the main institutional/industrial applicants over time
  • Main co-filings between applicants
  • Applicants and their affiliates

Analysis of inventors

  • List of the main inventors
  • Main research teams

Breakdown of the portfolio

  • Breakdown of the portfolio (for each breakdown are presented the distribution of technologies, the evolution of filings and the positioning of institutional applicants, industrial applicants and inventors)
  • Breakdown of the patent portfolio
    • 1/ Type of cell to be generated
    • 2/ Application of the patent family

Citation, extension & granted analysis

  • List of the most cited patents and patent applications
  • List of the most extended patents & patent applications
  • Granted patent families

Conclusive comments

Back to Top